Difficulty: Medium
Average Score: 64%
Testbank
A 74-year-old woman was diagnosed with rheumatoid arthritis 1 year ago, but has achieved adequate symptom control through the regular use of celecoxib (Celebrex), a COX-2 selective NSAID. The nurse should recognize that this drug, like other NSAIDs, influences what aspect of the pathophysiology of nociceptive pain?
Correct answer
D
Rationale
Inhibiting transduction by blocking the formation of prostaglandins in the periphery.
Celecoxib, as a COX-2 selective NSAID, reduces the synthesis of prostaglandins, which play a crucial role in the transduction of nociceptive pain signals. By decreasing prostaglandin levels, celecoxib effectively mitigates pain at the peripheral level, addressing the underlying pathophysiology of nociceptive pain associated with rheumatoid arthritis.
A: Distorting the action potential that is transmitted along the A-delta (d) and C fibers fails to apply here, as celecoxib does not alter the conduction of action potentials in these nerve fibers but rather reduces pain signaling through prostaglandin inhibition.
B: Diverting noxious information from passing through the dorsal root ganglia and synapses in the dorsal horn of the spinal cord is not relevant, since celecoxib works primarily at the peripheral level by inhibiting prostaglandin synthesis rather than affecting the transmission of signals within the central nervous system.
C: Blocking modulation by limiting the reuptake of serotonin and norepinephrine does not pertain to celecoxib's mechanism of action, as it primarily targets the inflammatory process by inhibiting prostaglandin formation rather than neurotransmitter reuptake in pain modulation pathways.
Celecoxib, as a COX-2 selective NSAID, reduces the synthesis of prostaglandins, which play a crucial role in the transduction of nociceptive pain signals. By decreasing prostaglandin levels, celecoxib effectively mitigates pain at the peripheral level, addressing the underlying pathophysiology of nociceptive pain associated with rheumatoid arthritis.
A: Distorting the action potential that is transmitted along the A-delta (d) and C fibers fails to apply here, as celecoxib does not alter the conduction of action potentials in these nerve fibers but rather reduces pain signaling through prostaglandin inhibition.
B: Diverting noxious information from passing through the dorsal root ganglia and synapses in the dorsal horn of the spinal cord is not relevant, since celecoxib works primarily at the peripheral level by inhibiting prostaglandin synthesis rather than affecting the transmission of signals within the central nervous system.
C: Blocking modulation by limiting the reuptake of serotonin and norepinephrine does not pertain to celecoxib's mechanism of action, as it primarily targets the inflammatory process by inhibiting prostaglandin formation rather than neurotransmitter reuptake in pain modulation pathways.